ERBB2 and breast cancer: Triple-negative breast cancer (TNBC) is defined as a tumor that lacks estrogen receptor, progesterone receptor, and human epidermal growth factor receptor (HER2) expression and represents approximately 15%–20% of breast cancer cases [1, 2].